Skip to main content
Caplight Logo









Olio

Olio

Private
Indianapolis, IndianaHealthcare & Life Scienceshttps://www.olio.health/

Last Round

Series B

May 12, 2025

Total Funding Raised

$26.5M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Olio is a healthcare technology company that provides a SaaS platform for care coordination between acute and post-acute providers to improve patient outcomes.

Sector

Healthcare & Life Sciences

Verticals

Vertical SaaS, Healthcare Analytics, Patient Engagement

Business Model

B2B

Customer Profile

Subscription SaaS

AI Layer

Application

Keywords

care coordinationpayer-provider collaborationhealthcare interoperabilityvertical SaaSworkflow automationhealth techclinical documentationAI-powered summarizationInsurTechhealthcare analyticspatient engagementHIPAA complianceHITRUSTcare managementhealth IT

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Olio Comparables

Compare Olio with similar companies based on industry and business-model similarity.

Olio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Post Acute Analytics
80%
Moxe Health
77%
Profility
73%

Olio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BMay 12, 2025
Series AAug 29, 2022
SeedMar 12, 2019

Key People

Founding team and executive leadership

Ben Forrest

CEO

Executive Team

Sean Lavies

Chief Technology Officer

Executive Team

Seth Baughman

CTO

Executive Team

Olio Investors

Notable investors and investment history

Olio investors
InvestorRounds
Mutual Capital PartnersSeries A, Series B
InnovatemapSeed
Fulcrum Equity PartnersSeries A, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 27, 2026

    Added Ecoactionhub, a healthcare SMB, as a customer.

  • Apr 21, 2026

    Partnering with AION Biosystems to capture early clinical deterioration signals.

Recent news

Latest coverage and updates

  • partners_withJun 18, 2026

    Olio Health, Inc. partnered with Sterlinghcm on Jun 18th '26.

Olio Filings

Explore SEC and related filing metadata, where available.

Olio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Olio's valuation, stock price, and market status.

Is Olio a public or private company?

Olio is a private company.

What is the current stock price of Olio?

Olio is a private company with no public stock price. No recent secondary market data is available.

How much is Olio worth (valuation)?

Valuation information for Olio is not publicly available.

Can I buy Olio stock?

Olio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Olio's last funding round?

Olio's most recent funding round was Series B on May 12, 2025.

Who are the main investors in Olio?

Key investors in Olio include Fulcrum Equity Partners.

Will Olio IPO soon?

No public IPO plans have been announced for Olio.

How can I track Olio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Olio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersIndianapolis, Indiana
Employee Range53
Year Founded2017
Last FundingMay 12, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?